03 May 2017
An article on the global alliance working to eliminate lymphatic filariasis (Espanol). El Pais, May 3, 2017.
27 April 2017
An article on how donors and drug firms are co-operating to defeat ancient plagues. The Economist, April 27, 2017.
19 April 2017
An article published on one of Tanzania’s leading English-language news sites, exploring the concept that eliminating NTDs should be focused on economically disadvantaged populations.
15 February 2017
Explore this article on the link between efforts to eliminate river blindness and the potential to reduce a mysterious and rare form of epilepsy.
30 January 2017
Article on The Task Force for Global Health: “You’ve heard of the CDC, but you probably didn’t know about this under-the-radar nonprofit.” Atlanta Magazine, January 2017.
21 December 2016
“Progress has been made in every area that makes disease elimination and eradication possible — from diagnosis and treatment to mapping and modelling.
21 November 2016
On behalf of Merck & Co., Inc.* and the Mectizan Donation Program, we are delighted to announce that Dr. Laurent Yaméogo was selected as the recipient of the 2015 Merck Mectizan Award in recognition of his contributions to the elimination of onchocerciasis (river blindness).
20 October 2016
An article discussing how transmission of disease occurs in only 9 of 36 Ugandan districts since eradication efforts began. Al Jazeera, October 20, 2016.
12 October 2016
Article covering the continued need for ivermectin (Mectizan®) to treat onchocerciasis. The Financial Times, October 12, 2016.
29 September 2016
Guatemala is the fourth country to eliminate river blindness! In a statement from Merck & Co., Inc. (known as MSD outside North America) Merck chairman and CEO Kenneth C.
02 September 2016
We are pleased to announce that Dr. Yao Sodahlon, MD, MSc, will become the next Director of the Mectizan Donation Program (MDP), beginning on October 17, 2016.
11 August 2016
Article about “breaking the life cycle” of onchocerca volvulu, the parasitic worm that causes onchocerciasis, commonly called river blindness. NPR, August 11, 2016.
12 May 2016
We are pleased to announce that Dr. Tony Ukety, former Coordinator for the Onchocerciasis Elimination NGDO Group was selected as the 2016 recipient of the Mectizan Award.
10 May 2016
Top: Dr. Adrian Hopkins receives Prince Abdulaziz Bin Ahmad Al Saud Prevention of Blindness Award in Bahrain from the President of the Middle East Africa Council on Opthalmology, Ahmed Abdulla Ahmed
04 May 2016
Merck & Co., Inc. and the MDP Donate $1 Million to the END Fund to Help Eliminate River Blindness in Africa
Since 1987 Merck & Co.
12 January 2016
An article describing the importance of and complexity in distributing ivermectin annually to people affected by onchocerciasis. NPR, January 14, 2016.
05 October 2015
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, proudly congratulates William C. Campbell (pictured/Reuters/Brian Snyder), a retired scientist from Merck Research Laboratories, who was jointly named the 2015 Nobel Prize winner in Physiology or Medicine with Satoshi Omura for the discovery of avermectin, which led to Merck’s development of Mectizan (ivermectin), a treatment for river blindness (also known as onchocerciasis) in Africa, Latin America and Yemen.